Abstract
Carbapenem-resistant Acinetobacter baumannii is becoming increasingly prevalent in patients with diabetes mellitus in the Middle East. We examined the relationship of these bacteria and their resistance mechanisms to the diabetic disease status of patients in Saudi Arabia. Susceptibilities of 271 isolates to carbapenems, tigecycline and colistin were determined, followed by detection of carbapenemase genes. A blaVIM gene was detected in ~95 % of isolates; blaOXA-23 and blaOXA-40 genes were also prevalent. Diabetic patients were significantly more likely to carry carbapenem-resistant isolates. Carbapenem-resistant A. baumannii is a serious problem in diabetic patients, and molecular detection of resistance mechanisms in these isolates is required.
| Original language | English |
|---|---|
| Pages (from-to) | 885-888 |
| Number of pages | 4 |
| Journal | Journal of Medical Microbiology |
| Volume | 62 |
| Early online date | 1 Jun 2013 |
| DOIs | |
| Publication status | Published - Jun 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acinetobacter Infections
- Acinetobacter baumannii
- Anti-Bacterial Agents
- Bacterial Proteins
- Carbapenems
- Diabetes Complications
- Diabetes Mellitus
- Drug Resistance, Bacterial
- Humans
- Microbial Sensitivity Tests
- Prevalence
- Saudi Arabia
- beta-Lactamases
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver